GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.41X leverage
Glenmark Pharmaceuticals live price: ₹2170.7. It opened at ₹2,242 vs previous close ₹2,256; intraday high/low: ₹2,266/₹2,164. The 50 & 200 DMA stand at ₹2,054.90/₹1,909.40.
Glenmark Pharmaceuticals Performance
- Low
- ₹2,164
- High
- ₹2,266
- 52 Week Low
- ₹1,336
- 52 Week High
- ₹2,298
- Open Price₹2,242
- Previous Close₹2,256
- Volume516,548
- 50 DMA₹2,054.90
- 100 DMA₹2,004.08
- 200 DMA₹1,909.40
Investment Returns
- Over 1 Month + 8.67%
- Over 3 Month + 9.91%
- Over 6 Month + 1.79%
- Over 1 Year + 54.48%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 57.5
- PEG Ratio
- 0.1
- Market Cap Cr
- 61,257
- P/B Ratio
- 6.1
- Average True Range
- 64.1
- EPS
- 95.92
- Dividend Yield
- 0.2
- MACD Signal
- 41.9
- RSI
- 57.69
- MFI
- 68.83
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,170.70
-85.7
(-3.8%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹2,118.85
- 50 Day
- ₹2,054.90
- 100 Day
- ₹2,004.08
- 200 Day
- ₹1,909.40
Resistance and Support
2200.13
- R3 2,338.87
- R2 2,302.43
- R1 2,236.57
- S1 2,134.27
- S2 2,097.83
- S3 2,031.97
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,170 As on 14 March, 2026 | 21:23
The Market Cap of Glenmark Pharmaceuticals is ₹61257.3 Cr As on 14 March, 2026 | 21:23
The P/E ratio of Glenmark Pharmaceuticals is 57.5 As on 14 March, 2026 | 21:23
The PB ratio of Glenmark Pharmaceuticals is 6.1 As on 14 March, 2026 | 21:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.